- Treatment of polycythemia vera with ropeginterferon alfa‑2b in a young woman with a successful pregnancy – case report2023 | Faculty of Medicine in Hradec Králové
- Aberrant expression of microRNA in polycythemia vera2008 | First Faculty of Medicine
- Regulated expression of microRNAs in normal and polycythemia vera erythropoiesis +12007 | First Faculty of Medicine
- Polycythemia vera2010 | First Faculty of Medicine
- Treatment of polycythemia vera2018 | Faculty of Medicine in Hradec Králové
- Event-free survival in patients with polycythemia vera treated with ropeginterferon alfa-2b versus best available treatment2023 | Publication without faculty affiliation
- Clinical and molecular characterisation of a prospectively collected cohort of children and adolescents with polycythemia vera2008 | Second Faculty of Medicine
- Polycythemia vera and other primary polycythemias2005 | First Faculty of Medicine
- Polycythemia vera and its molecular basis2006 | First Faculty of Medicine
- Imatinib effect on growth and signal transduction in polycythemia vera2007 | First Faculty of Medicine
- Polycythemia vera is not initiated by JAK2(V617F) mutation2007 | First Faculty of Medicine
- Imatinib effect on growth and signal transduction in polycythemia vera2007 | Faculty of Physical Education and Sport
- Polycythemia vera is not initiated by JAK2(V617F) mutation2007 | Faculty of Physical Education and Sport
- Recent advances in the molecular biology of congenital polycythemias and polycythemia vera2005 | First Faculty of Medicine
- Study of two tyrosine kinase inhibitors on growth and signal transduction in polycythemia vera2007 | First Faculty of Medicine
- Study of two tyrosine kinase inhibitors on growth and signal transduction in polycythemia vera2007 | Faculty of Physical Education and Sport
- Mutations of JAK2 in acute lymphoblastic leukaemias associated with Down's syndrome2008 | Second Faculty of Medicine
- Life expectancy and prognostic factors for survival in patients with polycythemia vera and essential thrombocythemia2005 | First Faculty of Medicine
- Final report of University Hospital Hradec Kralove to the clinical trial protocol no. PROUD-PVPublication without faculty affiliation
- Report of University Hospital Hradec Králové to the clinical trial protocol No: PROUD-PVPublication without faculty affiliation
- In vitro expansion of erythroid progenitors from polycythemia vera patients leads to decrease in JAK2 V617F allele2007 | First Faculty of Medicine
- Novel tumor antigens elicit anti-tumor humoral immune reactions in a subset of patients with polycythemia vera2007 | First Faculty of Medicine
- In vitro expansion of erythroid progenitors from polycythemia vera patients leads to decrease in JAK2 V617F allele2007 | Faculty of Physical Education and Sport
- Novel tumor antigens elicit anti-tumor humoral immune reactions in a subset of patients with polycythemia vera2007 | Faculty of Physical Education and Sport
- A novel uncoventional antigen MPD5 elicits anti-tumor humoral immune responses in a subset of patients with polycythemia vera2007 | First Faculty of Medicine
- A novel uncoventional antigen MPD5 elicits anti-tumor humoral immune responses in a subset of patients with polycythemia vera2007 | Faculty of Physical Education and Sport
- Coexistence of gain-of-function JAK2 germ line mutations with JAK2V617F in polycythemia vera2016 | Faculty of Science
- Research Report University Hospital of the clinical trial of PV-PROUDPublication without faculty affiliation
- Long-term outcomes of polycythemia vera patients treated with ropeginterferon Alfa-2b2022 | Publication without faculty affiliation